Nov 29 (Reuters) – The U.S. Food and Drug Administration could authorize COVID-19 boosters from Pfizer Inc (PFE.N) and BioNTech SE (22UAy.DE) for use in 16- and 17-year olds as soon as next week, the Wall Street Journal reported late on Monday, citing a person familiar with the planning.
Novo Nordisk contracts Aspen to produce insulin for Africa | Reuters Novo Nordisk (NOVOb.CO) has contracted...
Germany on Monday launched its autumn vaccination campaign to prevent respiratory infection, promoting an updated COVID-19...
Wendy Nelson stands at Uhuru Peak of Mt. Kilimanjaro, the highest point on the continent of...
Wendy Nelson watched her mother slowly die of Alzheimer’s disease, unable to move or swallow at...
Why Europe’s drug shortages may get worse | Reuter Most European countries reporting shortages of antibiotics...
